Paper34201212
Podocalyxin in Normal Tissue and Epithelial Cancer.
Le Tran N and 2 others. Cancers (Basel), 2021. Cited by 44 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Podocalyxin in Normal Tissue and Epithelial Cancer. Papers, record 34201212. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34201212
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 1156666 | National Health and Medical Research Council | PubMed |
Source PubMed
References130
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19,546,857 | Collective cell migration in morphogenesis, regeneration and cancer. | Nat Rev Mol Cell Biol | 2009 | https://conductscience.org/library/papers/19546857 | PubMed |
| 2 | 25,915,207 | Bmi1 essentially mediates podocalyxin-enhanced Cisplatin chemoresistance in oral tongue squamous cell carcinoma. | PLoS One | 2015 | https://conductscience.org/library/papers/25915207 | PubMed |
| 3 | 15,009,070 | Podocalyxin in human haematopoietic cells. | Br J Haematol | 2004 | https://conductscience.org/library/papers/15009070 | PubMed |
| 4 | 23,819,542 | Podocalyxin-like protein expression in primary colorectal cancer and synchronous lymph node metastases. | Diagn Pathol | 2013 | https://conductscience.org/library/papers/23819542 | PubMed |
| 5 | 29,245,936 | Podocalyxin promotes proliferation and survival in mature B-cell non-Hodgkin lymphoma cells. | Oncotarget | 2017 | https://conductscience.org/library/papers/29245936 | PubMed |
| 6 | 3,511,072 | Endothelial cell membranes contain podocalyxin--the major sialoprotein of visceral glomerular epithelial cells. | J Cell Biol | 1986 | https://conductscience.org/library/papers/3511072 | PubMed |
| 7 | 15,701,716 | Podocalyxin is a CD34-related marker of murine hematopoietic stem cells and embryonic erythroid cells. | Blood | 2005 | https://conductscience.org/library/papers/15701716 | PubMed |
| 8 | 16,684,343 | Role of transcription factor Sp1 and CpG methylation on the regulation of the human podocalyxin gene promoter. | BMC Mol Biol | 2006 | https://conductscience.org/library/papers/16684343 | PubMed |
| 9 | 23,652,315 | Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer. | Br J Cancer | 2013 | https://conductscience.org/library/papers/23652315 | PubMed |
| 10 | 28,004,467 | Podocalyxin influences malignant potential by controlling epithelial-mesenchymal transition in lung adenocarcinoma. | Cancer Sci | 2017 | https://conductscience.org/library/papers/28004467 | PubMed |
| 11 | 30,044,991 | Epithelial-Mesenchymal Transition Induces Podocalyxin to Promote Extravasation via Ezrin Signaling. | Cell Rep | 2018 | https://conductscience.org/library/papers/30044991 | PubMed |
| 12 | 25,286,028 | Oncogenic roles of Bmi1 and its therapeutic inhibition by histone deacetylase inhibitor in tongue cancer. | Lab Invest | 2014 | https://conductscience.org/library/papers/25286028 | PubMed |
| 13 | 24,821,609 | Podocalyxin-like 1 is associated with tumor aggressiveness and metastatic gene expression in human oral squamous cell carcinoma. | Int J Oncol | 2014 | https://conductscience.org/library/papers/24821609 | PubMed |
| 14 | 24,970,760 | Podocalyxin-like 1 promotes invadopodia formation and metastasis through activation of Rac1/Cdc42/cortactin signaling in breast cancer cells. | Carcinogenesis | 2014 | https://conductscience.org/library/papers/24970760 | PubMed |
| 15 | 10,982,412 | Expression of podocalyxin inhibits cell-cell adhesion and modifies junctional properties in Madin-Darby canine kidney cells. | Mol Biol Cell | 2000 | https://conductscience.org/library/papers/10982412 | PubMed |
| 16 | 21,829,192 | Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer. | Br J Cancer | 2011 | https://conductscience.org/library/papers/21829192 | PubMed |
| 17 | 25,316,657 | FAK signaling in human cancer as a target for therapeutics. | Pharmacol Ther | 2015 | https://conductscience.org/library/papers/25316657 | PubMed |
| 18 | 11,457,870 | New functions for the NHERF family of proteins. | J Clin Invest | 2001 | https://conductscience.org/library/papers/11457870 | PubMed |
| 19 | 15,923,169 | Podocalyxin: a marker of blasts in acute leukemia. | Am J Clin Pathol | 2005 | https://conductscience.org/library/papers/15923169 | PubMed |
| 20 | 28,187,288 | Emerging Biological Principles of Metastasis. | Cell | 2017 | https://conductscience.org/library/papers/28187288 | PubMed |
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,883,894 | The Glyco-Code Molecular Template Instructively Guides Skeletal and Neural Development, Tissue Regeneration and Dynamic Repair Responses Following Trauma and Disease. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42883894 | PubMed |
| 42,882,913 | PODXL2 Expression Is Associated with Inferior Survival, Adverse-Risk Features, and Distinct Transcriptional Programs in Acute Myeloid Leukemia. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42882913 | PubMed |
| 42,535,754 | Keratan Sulfate: An Electroconductive Glycosaminoglycan at the Interface of Sensory Perception and Neural Signaling. | J Neurosci Res | 2026 | https://conductscience.org/library/papers/42535754 | PubMed |
| 42,343,334 | Podocalyxin may be down-regulated by progesterone in high grade serous ovarian cancer spheroids to increase responsiveness to carboplatin and NK cells. | BMC Cancer | 2026 | https://conductscience.org/library/papers/42343334 | PubMed |
| 42,243,490 | Urinary vesicle biomarkers and kidney function-results from the German AugUR study. | Sci Rep | 2026 | https://conductscience.org/library/papers/42243490 | PubMed |
| 41,718,268 | Structural and Dynamic Insights into Podocalyxin-Ezrin Interaction as a Target in Cancer Progression. | J Xenobiot | 2026 | https://conductscience.org/library/papers/41718268 | PubMed |
| 41,462,970 | Podocalyxin, Isthmin-1, and Pentraxin-3 Immunoreactivities as Emerging Immunohistochemical Markers of Fibrosis in Chronic Hepatitis B. | Biomedicines | 2025 | https://conductscience.org/library/papers/41462970 | PubMed |
| 41,327,293 | Podocalyxin and ciliary neurotrophic factor receptor are novel components of the surfaceome of chondrogenic cells. | Cell Commun Signal | 2025 | https://conductscience.org/library/papers/41327293 | PubMed |
| 41,168,712 | Podocalyxin protects high grade serous ovarian cancer spheroids from NK cell infiltration and spheroid destruction. | BMC Cancer | 2025 | https://conductscience.org/library/papers/41168712 | PubMed |
| 41,000,854 | Expression of vimentin intermediate filaments in epithelial cells promotes cell migration and cell matrix interaction in 3D. | bioRxiv | 2025 | https://conductscience.org/library/papers/41000854 | PubMed |
| 40,862,528 | Keratan Sulfate Is a Multifunctional Brain Glycosaminoglycan With Instructive Capabilities. | J Neurochem | 2025 | https://conductscience.org/library/papers/40862528 | PubMed |
| 40,843,679 | A Cancer-Specific Anti-Podocalyxin Monoclonal Antibody (humPcMab-60) Demonstrated Antitumor Efficacy in Pancreatic and Colorectal Cancer Xenograft Models. | Antibodies (Basel) | 2025 | https://conductscience.org/library/papers/40843679 | PubMed |
| 40,386,618 | A prognostic nomogram based on desmoplastic reaction/tumor deposit modified lymph node staging in colorectal cancer. | J Gastrointest Oncol | 2025 | https://conductscience.org/library/papers/40386618 | PubMed |
| 40,141,196 | Glycosaminoglycans, Instructive Biomolecules That Regulate Cellular Activity and Synaptic Neuronal Control of Specific Tissue Functional Properties. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40141196 | PubMed |
| 40,136,401 | Identification and Validation of Key Biomarkers in the Proximal Aqueous Humor Outflow Pathway. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/40136401 | PubMed |
| 39,795,629 | Anti-Adhesive Podocalyxin Expression Is Disrupted in Recurrent Implantation Failure. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/39795629 | PubMed |
| 39,697,970 | Hydroxytyrosol's Protective Effect Through Podocalyxin and Pentraxin-3 in Kidney Damage Resulting From Corn Syrup Administration. | Cureus | 2024 | https://conductscience.org/library/papers/39697970 | PubMed |
| 39,518,828 | Towards the Identification of New Biomarkers in Saliva and Serum for Treatment Monitoring of Equine Gastric Ulcer Syndrome: A Liquid Proteomic Approach. | Animals (Basel) | 2024 | https://conductscience.org/library/papers/39518828 | PubMed |
| 39,399,491 | Molecular landscape of kidney allograft tissues data integration portal (NephroDIP): a curated database to improve integration of high-throughput kidney transplant datasets. | Front Immunol | 2024 | https://conductscience.org/library/papers/39399491 | PubMed |
| 39,391,792 | In vitro vascularization of 3D cell aggregates in microwells with integrated vascular beds. | Mater Today Bio | 2024 | https://conductscience.org/library/papers/39391792 | PubMed |
Genes36
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34201212
GET https://conductscience.org/api/papers/v1/34201212/references?page=2